Biogen Archives - Express Pharma

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

Shares of Japan’s Eisai tumble after EU rejects Alzheimer’s drug

Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says GlobalData

Alzheimer’s drug Leqembi launched by Eisai, Biogen in China

Pharma industry focuses on strategic investments amid reduced deal activity by 26.1 % compared to May 2023: GlobalData

Biogen receives EC approval for QALSODY to treat rare genetic form of ALS

Biogen, Ionis terminates development of ALS investigational drug

Eisai submits MAA for lecanemab in Great Britain to treat early Alzheimer’s disease

USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM Alzheimer’s treatment